111/121 diplotype of Calpain-10 is associated with the risk of polycystic ovary syndrome in Korean women

Fertility and Sterility

Volumn 92, Issue 2, 2009, Pages 830-833

  Lee, Ji Young ^a   Lee, Woon Jeong ^b   Hur, Sung Eun ^c   Lee, Chul Min ^d   Sung, Yeon Ah ^b   Chung, Hye Won ^b  

^a Konkuk University School of Medicine   (South Korea)

^b Ewha Womans University School of Medicine   (South Korea)

^c Konyang University   (South Korea)

^d Inje University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CALPAIN 10;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HAPLOTYPE; HUMAN; KOREA; MAJOR CLINICAL STUDY; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; QUANTITATIVE TRAIT;

ADULT; CALPAIN; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INCIDENCE; KOREA; POLYCYSTIC OVARY SYNDROME; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK ASSESSMENT; RISK FACTORS;

EID: 67651099079     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2008.06.023     Document Type: Article

References (32)

1. Legro R.S., and Strauss J.F. Molecular progress in infertility: polycystic ovary syndrome. Fertil Steril 78 (2002) 569-576
2. Carey A.H., Waterworth D., Patel K., White D., Little J., Novelli P., et al. Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene CYP17. Hum Mol Genet 3 (1994) 1873-1876
3. Gharani N., Waterworth D.M., Batty S., White D., Gilling-Smith C., Conway G.S., et al. Association of the steroid synthesis gene CYP11a with polycystic ovary syndrome and hyperandrogenism. Hum Mol Genet 6 (1997) 397-402
4. Urbanek M., Legro R.S., Driscoll D.A., Azziz R., Ehrmann D.A., Norman R.J., et al. Thirty-seven candidate genes for polycystic ovary syndrome: strongest evidence for linkage is with follistatin. Proc Natl Acad Sci U S A 96 (1999) 8573-8578
5. Elter K., Erel C.T., Cine N., Ozbek U., Hacihanefioglu B., and Ertungealp E. Role of the mutations Trp8Arg and Ile15Thr of the human luteinizing hormone ß-subunit in women with polycystic ovary syndrome. Fertil Steril 71 (1999) 425-430
6. Conway G.S., Conway E., Walker C., Hoppner W., Gromoll J., and Simoni M. Mutation screening and isoform prevalence of the follicle stimulating hormone receptor gene in women with premature ovarian failure, resistant ovary syndrome and polycystic ovary syndrome. Clin Endocrinol 51 (1999) 97-99
7. McKeigue P., and Wild S. Association of insulin gene VNTR polymorphism with polycystic ovary syndrome. Lancet 349 (1997) 1771-1772
8. Waterworth D.M., Bennett S.T., Gharani N., McCarthy M.I., Hague S., Batty S., et al. Linkage and association of insulin gene VNTR regulatory polymorphism with polycystic ovary syndrome. Lancet 349 (1997) 986-990
9. Talbot J.A., Bicknell E.J., Rajkhowa M., Krook A., O'Rahilly S., and Clayton R.N. Molecular scanning of the insulin receptor gene in women with polycystic ovarian syndrome. J Clin Endocrinol Metab 81 (1996) 1979-1983
10. Kiddy D.S., Sharp P.S., White D.M., Scanion M.F., Mason H.D., Bray C.S., et al. Differences in clinical and endocrine features between obese and nonobese subjects with polycystic ovary syndrome: an analysis of 263 consecutive cases. Clin Endocrinol 32 (1990) 213-220
11. Dunaif A., Xia J., Book C.B., Schenker E., and Tang Z. Excessive insulin receptor phosphorylation in cultured fibroblasts and in skeletal muscle. J Clin Invest 96 (1995) 801-810
12. Dunaif A., Segal K.R., Futterweit W., and Dobrjansky A. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes 38 (1989) 1165-1174
13. Dunaif A. Hyperandrogenic anovulation (PCOS): a unique disorder of insulin action associated with an increased risk of noninsulin-dependent diabetes mellitus. Am J Med 98 (1995) 33S-39S
14. Roldan B., San Millan J.L., and Escobar-Morreale H.F. Genetic basis of metabolic abnormalities in polycystic ovary syndrome: implications for therapy. Am J Pharmacogenomics 4 (2004) 93-107
15. Hanis C.L., Boerwinkle E., Chakraborty R., Ellsworth D.L., Concannon P., Stirling B., et al. A genome-wide search for human noninsulin-dependent (type 2) diabetes genes reveals a major susceptibility locus on chromosome 2. Nat Genet 13 (1996) 161-166
16. Horikawa Y., Oda N., Cox N.J., Li X., Orho-Melander M., Hara M., et al. Genetic variation in the gene encoding Calpain-10 is associated with type 2 diabetes mellitus. Nat Genet 26 (2000) 163-175
17. Sreenan S.K., Zhou Y.P., Otani K., Hansen P.A., Currie K.P., Pan C.Y., et al. Calpain plays a role in insulin secretion and action. Diabetes 50 (2001) 2013-2020
18. Ehrmann D.A., Schwarz P.E.H., Hara M., Tang X., Horikawa Y., Imperial J., et al. Relationship of Calpain-10 genotype to phenotypic features of polycystic ovary syndrome. J Clin Endocrinol Metab 87 (2002) 1669-1673
19. Horikawa Y., Oda N., Yu L., Imamura S., Fujiwara K., Makino M., et al. Genetic variation in Calpain-10 gene are not a major factor in the occurrence of type 2 diabetes in Japanese. J Clin Endocrinol Metab 88 (2003) 244-247
20. Kang ES, Nam MS, Kim HJ, M SM, Rhee Y, et al. Haplotype combination of Calpain-10 gene polymorphism is associated with metabolic syndrome in type 2 diabetes. Diabetes Res Clin Pract 2006;73:268-75.
21. Kang E.S., Kim H.J., Nam M.S., Nam C.M., Ahn C.W., Cha B.S., et al. A novel 111/121 diplotype in the Calpain-10 gene is associated with type 2 diabetes. J Hum Genet 51 (2006) 629-633
22. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and longterm health risks related to polycystic ovary syndrome (PCOS). Hum Repord 19 (2004) 41-47
23. Niu T., Qin Z.S., Xu X., and Liu J.S. Bayesian haplotype inference for multiple linked single-nucleotide polymorphism. Am J Hum Genet 70 (2002) 157-169
24. Malecki M.T., Moczulski D.K., Klupa T., Wanic K., Cyganek K., Frey J., et al. Homozygous combination of Calpain 10 gene haplotype is associated with type 2 diabetes mellitus in a Polish population. Eur J Endocrinol 146 (2002) 695-699
25. Iwasaki N., Horikawa Y., Tsuchiya T., Kitamura Y., Nakamura T., Tanizawa Y., et al. Genetic variants in the Calpain-10 gene and the development of type 2 diabetes in the Japanese population. J Hum Genet 50 2 (2005) 92-98
26. Deedwania P.C., Hunninghake D.B., Bays H.E., Jones P.H., Cain V.A., and Blasetto J.W. STELLAR Study Group. Effects of rosuvastatin, atorvastatin, simvasttin, and pravastatin on atherogenic dyslipidemia in patients with characteristics of the metabolic syndrome. Am J Cardiol 95 (2005) 360-366
27. Lansang M.C., Williams G.H., and Carroll J.S. Correlation between the glucose clamp technique and the homeostasis model assessment inhypertension. Am J Hypertens 14 (2001) 51-53
28. Hoeger K.M. Role of lifestyle modification in the management of polycystic ovary syndrome. Best Pract Res Clin Endocrinol Metab 20 (2006) 293-310
29. Salley K.E.S., Wickham E.P., Cheang K.I., Essah P.A., Karjane N.W., and Nestler J.E. Position statement: glucose intolerance in polycystic ovary syndrome-position statement of the Androgen Excess Society. J Clin Endocrinol Metab 92 (2007) 4546-4556
30. Stam L.F., and Laurie C.C. Molecular dissection of a major gene effect on a quantitative trait: the level of alcohol dehydrogenase expression in Drosophila melanogaster. Genetics (1993) 1559-1564
31. Uitterlinden A.G., Burger H., Huang Q., Yue F., McGuigan F.E., Grant S.F., et al. Relation of alleles of the collagen type Ialpha1 gene to bone density and the risk of osteoporotic fractures in postmenopausal women. N Engl J Med 338 (1998) 1016-1021
32. Baier L.J., Permana P.A., Yang X., Pratley R.E., Hanson R.L., Shen G.Q., et al. A Calpain-10 gene polymorphism is associated with reduced muscle mRNA levels and insulin resistance. J Clin Invest 106 (2000) R69-R73